US Patent 7943170 Sustained release paracetamol containing compositions
Patent 7943170 was granted and assigned to Smithkline Beecham Limited on May, 2011 by the United States Patent and Trademark Office.
All edits
Edits on 27 Nov, 2023
Golden AI
Edits made to:
Article (+241 characters)
Article
Patent abstract
A pharmaceutical composition comprising an immediate release phase and a sustained release phase of paracetamol is described which has a unique in vitro dissolution profile resulting in advantageous pharmacokinetic properties.
Edits on 19 Sep, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
Bounkhiene Sengmanee0
Shing Yue Chan0
Timothy James Grattan0
Edits on 15 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07943170 Sustained release paracetamol containing compositions US Patent 7943170 Sustained release paracetamol containing compositions
Infobox
Patent Number
079431700
Patent Number
79431700
Edits on 30 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
079431700
Date of Patent
May 17, 2011
0Patent Application Number
102570770
Date Filed
April 12, 2001
0Patent Primary Examiner
Edits on 7 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07943170 Sustained release paracetamol containing compositions
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07943170
Date of patent
May 17, 2011
Patent application number
10257077
Date Filed
April 12, 2001
Patent primary examiner
Find more entities like US Patent 7943170 Sustained release paracetamol containing compositions
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
